SCHEDULE: Guardians of NZ Superannuation Discloses LanzaTech Stake
Schedule 13G Filing
Guardians of New Zealand Superannuation has reported a beneficial ownership of 1,302,492 shares, representing 12.9% of LanzaTech Global, Inc.'s common stock as of March 31, 2026.
Summary
- Guardians of New Zealand Superannuation (the Reporting Person) has filed a Schedule 13G, indicating their beneficial ownership of LanzaTech Global, Inc. common stock.
- The Reporting Person holds 1,302,492 shares, which constitutes 12.9% of the class of securities.
- This ownership level is calculated based on 10,089,163 outstanding common shares as of April 28, 2026, as reported by LanzaTech in its definitive proxy statement.
- The filing is an amendment (Amendment No. 1) to a previous filing.
- The Reporting Person certifies that the securities were not acquired or held for the purpose of influencing the control of the issuer.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. It is a standard disclosure of beneficial ownership and does not provide new operational or financial information about the company itself.
Positives
- Significant ownership stake of 12.9% by a major institutional investor, Guardians of New Zealand Superannuation, indicates confidence in LanzaTech's long-term prospects.
- The filing is an amendment, suggesting ongoing management of the investment rather than a new, potentially disruptive acquisition.
Negatives
- The filing does not contain any negative financial or operational information about LanzaTech; it solely reports ownership.
Risks
- As a significant shareholder, Guardians of New Zealand Superannuation's future investment decisions could impact LanzaTech's stock price.
- The filing does not detail specific risks related to LanzaTech's business operations, but general market risks for technology and industrial companies would apply.
Future Outlook
The filing itself does not contain forward-looking statements or guidance from LanzaTech. It is a disclosure of ownership by an institutional investor.
Industry Context
StockSavvy.ai notes that institutional investor filings like this Schedule 13G are common for publicly traded companies and provide transparency regarding significant ownership. The size of the stake held by Guardians of New Zealand Superannuation suggests a notable level of institutional interest in LanzaTech's sector, which is focused on carbon capture and sustainable fuels.
Stakeholder Impact
- Shareholders: The filing provides transparency on a significant institutional shareholder, which can influence investor perception and market dynamics.
- LanzaTech Management: The filing confirms a substantial holding by Guardians of New Zealand Superannuation, which may be a factor in future corporate governance discussions.
- Potential Investors: The disclosure of a large stake by a sovereign wealth fund can be seen as a positive signal, potentially attracting further investment.
Next Steps
- Guardians of New Zealand Superannuation will continue to monitor their investment in LanzaTech Global, Inc.
- LanzaTech Global, Inc. will continue its business operations and reporting as per SEC regulations.
Key Dates
| Date | Description |
|---|---|
| 03/31/2026 | Date of Event Which Requires Filing of this Statement |
| 04/28/2026 | Date as of which outstanding common shares were reported by the Issuer. |
| 04/29/2026 | Date LanzaTech Global, Inc. filed its definitive proxy statement with the SEC. |
| 05/11/2026 | Date of Certification and Signature on the Schedule 13G filing. |
Keywords
LanzaTech Global, Schedule 13G, Guardians of New Zealand Superannuation, Common Stock, Beneficial Ownership, SEC Filing, Investment, Shareholder
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.